| Old Articles: <Older 41511-41520 Newer> |
|---|
 |
The Motley Fool
June 4, 2010
Brian Orelli |
Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other.   |
The Motley Fool
June 4, 2010 |
CAPS' Weekly Top Stock Idea Motley Fool's investing community's latest prime pick is GameStop. Read on to see why. |
The Motley Fool
June 4, 2010
Jordan DiPietro |
The Markets' Biggest Movers After a year-long recovery in the market, stocks have recently taken a turn for the worst. Despite strong corporate earnings in the first quarter and a rebound in consumer spending, investors are now bracing themselves for what could be a major correction or even a bear market. |
The Motley Fool
June 4, 2010
Joe Magyer |
Paychex: Strengths, Weaknesses, Opportunities, Threats Paychex provides payroll and HR services to small businesses, but this business is in no way small. |
The Motley Fool
June 4, 2010
Jordan DiPietro |
3 Stocks Lynch Might Love Peter Lynch had a knack for finding high-quality growth stocks like these. |
The Motley Fool
June 4, 2010
Anand Chokkavelu |
Roundtable: The Best Stock Right Now Motley Fool analysts give you their picks for the best buying opportunities right now. |
The Motley Fool
June 4, 2010
Anand Chokkavelu |
One Big Stock Idea: Aflac A conversation with Aflac CEO Dan Amos. |
The Motley Fool
June 4, 2010
Bruce V. Bigelow |
Looking for an Exit What are the factors affecting IPOs, and what kind of guidance are experienced CEOs and other experts offering about taking startups public? Startup founders, investors, and bankers offer some IPO guidance. |
The Motley Fool
June 4, 2010
Rick Aristotle Munarriz |
7 Reasons to Worry About Next Week Let's go over a few stocks that are expected to go the wrong way on the bottom line next week: Bob Evans... Brown-Forman... Ciena... Titan Machinery... ArcSight... Del Monte... China Biotics... |
The Motley Fool
June 4, 2010
Anand Chokkavelu |
BP = Big Punchline Since its spill on April 20, BP has gone from a blue chip to a black comedy. It's lost almost 40% of its market value, and its efforts to stem the oil leak in the Gulf have been, well, unsuccessful. |
| <Older 41511-41520 Newer> Return to current articles. |
